AMRN Wutah bathi saben saham ing taun iki amarincorp.com

AMRN (Amarin Corporation plc) - tandha merek perusahaan

Steady demand for cardiology treatments ensures the resilience of Amarin Corporation plc (AMRN) during any crisis. The year-over-year percentage growth rate of earnings per share confirms this foundation, where -1150.10 reflects the latest metric value. The uniqueness of the drug Vascepa integrates the company into global medical standards, although the product's maturity stage necessitates the search for new sales markets to combat generics.

AMRN (Amarin Corp) riwayat Wutah bathi ing taun lumaku saka 04.07.2022 nganti 17.11.2026

Rincian analitis lan laporan data perusahaan Amarin (AMRN)

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis dhasar perusahaan:Amarin Pharma AMRN
Produk mawa merek amarincorp.com

This indicator measures the year-over-year growth rate of earnings per share, reflecting capital management efficiency and the business's ability to generate income. By analyzing the annual EPS growth rate, an investor assesses the impact of patent protection and the global expansion of Amarin Corporation plc (AMRN) on gross margins, which directly determines the sustainability of operating cash flow.